Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   Dietary Patterns, Apolipoprotein L1 Risk Genotypes, and CKD Outcomes Among Black Adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study
  2. Ilori, Titilayo O; Brooks, Marquita S; Desai, Parin N; Cheung, Katharine L; Judd, Suzanne E; Crews, Deidra C; Cushman, Mary; Winkler,Cheryl; Shlipak, Michael G; Kopp, Jeffrey B; Naik, Rakhi P; Estrella, Michelle M; Gutiérrez, Orlando M; Kramer, Holly
  3. Kidney Medicine. 2023, May; 5(5): 100621.
  1. 2.   Rotavirus Strain Surveillance in Estonia After Introduction of Rotavirus Universal Mass Vaccination
  2. Koivumagi, Kadri; Soeorg, Hiie; Toompere, Karolin; Kallas, Eveli; Joegeda, Ene-Ly; Lass, Evely; Huik,Kristi; Lutsar, Irja
  3. The Pediatric Infectious Disease Journal. 2021, May 01; 40(5): 489-494.
  1. 3.   Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations
  2. Hiby, S. E.; Ashrafian-Bonab, M.; Farrell, L.; Single, R. M.; Balloux, F.; Carrington, M.; Moffett, A.
  3. Immunogenetics. 2010, Feb; 62(2): 65-73.
  1. 4.   GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese
  2. Guo, X. C.; O'Brien, S. J.; Zeng, Y.; Nelson, G. W.; Winkler, C. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(7): 1760-1763.
  1. 5.   Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis
  2. Goodman, J. E.; Mechanic, L. E.; Luke, B. T.; Ambs, S.; Chanock, S.; Harris, C. C.
  3. International Journal of Cancer. 2006, Apr; 118(7): 1790-1797.
  1. 6.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 7.   Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance
  2. Bergen, A. W.; Qi, Y.; Haque, K. A.; Welch, R. A.; Chanock, S. J.
  3. BMC Biotechnology. 2005, SEP 16; 5
  1. 8.   CYP1A1 Val(462) and NQO1 Ser(187) polymorphisms, cigarette use, and risk for colorectal adenoma
  2. Hou, L. F.; Chatterjee, N.; Huang, W. Y.; Baccarelli, A.; Yadavalli, S.; Yeager, M.; Bresalier, R. S.; Chanock, S. J.; Caporaso, N. E.; Ji, B. T.; Weissfeld, J. L.; Hayes, R. B.
  3. Carcinogenesis. 2005, JUN; 26(6): 1122-1128.
  1. 9.   Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
  2. Carrington, M.; Wang, S.; Martin, M. P.; Gao, X. J.; Schiffman, M.; Cheng, J.; Herrero, R.; Rodriguez, A. C.; Kurman, R.; Mortel, R.; Schwartz, P.; Glass, A.; Hildesheim, A.
  3. Journal of Experimental Medicine. 2005, APR 4; 201(7): 1069-1075.
  1. 10.   Cytonuclear genomic dissociation in African elephant species
  2. Roca, A. L.; Georgiadis, N.; O'Brien, S. J.
  3. Nature Genetics. 2005, JAN; 37(1): 96-100.
  1. 11.   Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma
  2. Huang, W. Y.; Chatterjee, N.; Chanock, S.; Dean, M.; Yeager, M.; Schoen, R. E.; Hou, L. F.; Berndt, S. I.; Yadavalli, S.; Johnson, C. C.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, JAN; 14(1): 152-157.
  1. 12.   Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression
  2. Szapacs, M. E.; Mathews, T. A.; Tessarollo, L.; Lyons, W. E.; Mamounas, L. A.; Andrews, A. M.
  3. Journal of Neuroscience Methods. 2004, DEC 30; 140(1-2): 81-92.
  1. 13.   Estrogen receptor genotypes and haplotypes associated with breast cancer risk
  2. Gold, B.; Kalush, F.; Bergeron, J.; Scott, K.; Mitra, N.; Wilson, K.; Ellis, N.; Huang, H.; Chen, M.; Lippert, R.; Halldorsson, B. V.; Woodworth, B.; White, T.; Clark, A. G.; Parl, F. F.; Broder, S.; Dean, M.; Offit, K.
  3. Cancer Research. 2004, DEC 15; 64(24): 8891-8900.
  1. 14.   Murine T cells potently restrict human immunodeficiency virus infection
  2. Baumann, J. G.; Unutmaz, D.; Miller, M. D.; Breun, S. K. J.; Grill, S. M.; Mirro, J.; Littman, D. R.; Rein, A.; KewalRamani, V. N.
  3. Journal of Virology. 2004, NOV; 78(22): 12537-12547.
  1. 15.   MBL2 genotypes are important determinants of HBV clearance or persistence
  2. Thio, C. L.; Mosbruger, T.; Astemborski, J.; Greer, S.; Vlahov, D.; O'Brien, S.; Thomas, D.
  3. Hepatology. 2004, OCT; 40(4, Suppl. 1): 594A-595A.
  1. 16.   Cutting edge: Heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis
  2. Nelson, G. W.; Martin, M. P.; Gladman, D.; Wade, J.; Trowsdale, J.; Carrington, M.
  3. Journal of Immunology. 2004, OCT 1; 173(7): 4273-4276.
  1. 17.   APOBEC3G genetic variants and their influence on the progression to AIDS
  2. An, P.; Bleiber, G.; Duggal, P.; Nelson, G.; May, M.; Mangeat, B.; Alobwede, I.; Trono, D.; Vlahov, D.; Donfield, S.; Goedert, J. J.; Phair, J.; Buchbinder, S.; O'Brien, S. J.; Telenti, A.; Winkler, C. A.
  3. Journal of Virology. 2004, OCT; 78(20): 11070-11076.
  1. 18.   Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: Role of glutathione S-transferase genotypes
  2. Hakim, I. A.; Harris, R. B.; Chow, H. H. S.; Dean, M.; Brown, S.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004 13(2): 242-249.
  1. 19.   Methods for high-density admixture mapping of disease genes
  2. Patterson, N.; Hattangadi, N.; Lane, B.; Lohmueller, K. E.; Hafler, D. A.; Oksenberg, J. R.; Hauser, S. L.; Smith, M. W.; O'Brien, S. J.; Altshuler, D.; Daly, M. J.; Reich, D.
  3. American Journal of Human Genetics. 2004 74(5): 979-1000.
  1. 20.   Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes
  2. Penzak, S. R.; Shen, J. M.; Alfaro, R. M.; Remaley, A. T.; Natarajan, V.; Falloon, J.
  3. Therapeutic Drug Monitoring. 2004 26(3): 322-330.
  1. 21.   Low frequency non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant variants contribute to failure of efavirenz-containing regimens in NNRTI-experienced patients with negative standard genotypes for NNRTI mutations
  2. Mellors, J.; Palmer, S.; Nissley, D.; Kearney, M.; Halvas, E.; Bixby, C.; Demeter, L.; Eshleman, S.; Bennett, K.; Hart, S.; Vaida, F.; Wantman, M.; Coffin, J.; Hammer, S.
  3. Antiviral Therapy. 2003, JUN; 8(3): U129, Abstract 134-U130, Abstract 134.
  1. 22.   Population survey of CCR5 Delta 32, CCR5 m303, CCR2b 64I, and SDF1 3 ' A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups
  2. Wang, F. S.; Hong, W. G.; Cao, Y. Z.; Liu, M. X.; Jin, L.; Hu, L. P.; Wang, Z.; Feng, T. J.; Hou, J.; Zhang, B.; Shi, M.; Xu, D. P.; Lei, Z. Y.; Wang, B.; Liu, Z. D.; Ye, J. J.; Peng, L.; Qiu, Y.; Winkler, C.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2003 32(2): 124-130.
  1. 23.   Polymorphisms in inflammatory cytokines and Fc gamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study
  2. Foster, C. B.; Zhu, S. X.; Erichsen, H. C.; Lehrnbecher, T.; Hart, E. S.; Choi, E.; Stein, S.; Smith, M. W.; Steinberg, S. M.; Imbach, P.; Kuhne, T.; Chanock, S. J.
  3. British Journal of Haematology. 2001 113(3): 596-599.
  1. 24.   Genetic heterogeneity and molecular epidemiology of GB virus C hepatitis G virus in China
  2. An, P.; Luo, H.; Lu, T.; O'Brien, S. J.; Winkler, C.
  3. Journal of Human Virology. 2000, NOV-DEC; 3(6): 299-305.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel